US FDA lifts clinical hold on Novavax's combo COVID-flu shot
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated ...
MarketWatch23d
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine ... combined shot. Meanwhile, Moderna said last week that it plans to file for FDA approval of its own combo vaccine ...
Yahoo Finance23d
FDA lifts pause on Novavax flu vaccine trials
The lifted hold applies to Novavax’s flu ... combo vaccine. A trial participant who’d received the shot in Jan. 2023 later developed motor neuropathy, or muscle weakness, leading the FDA ...
Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold
Novavax said the Food and Drug Administration allowed it to continue testing a combination COVID-19-flu and standalone flu vaccine that had been put on hold.
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
(Reuters) -The U.S ... hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety ...